Your fight against colorectal
cancer (MSI‑H/dMMR) may
continue here
OPDIVO, alone or with YERVOY, is an FDA-approved immunotherapy option to treat advanced colorectal cancer (MSI-H/dMMR)
Your fight against colorectal
cancer (MSI‑H/dMMR) may
continue here
OPDIVO, alone or with YERVOY, is an FDA-approved immunotherapy option to treat advanced colorectal cancer (MSI-H/dMMR)
Actor portrayals.
OPDIVO or OPDIVO + YERVOY is not approved
for people younger than 12 years of age.
OPDIVO + YERVOY is a treatment option for certain adults and children 12 years and older who have had prior treatments for MSI-H/dMMR colorectal cancer
OPDIVO is a treatment option for certain adults and children 12 years and older who have had prior treatments for MSI-H/dMMR colorectal cancer
OPDIVO will not work for everyone. Individual results may vary.